Wall Street’s main indexes hit their lowest levels in six weeks on Monday after Republicans pulled a healthcare bill, raising questions about President Donald Trump’s ability to deliver on his ambitious economic agenda. With the decline, the Dow Jones Industrial Average is on track to record its longest losing streak in six years, according to The Wall Street Journal. The bill, which was set to overhaul the Affordable Care Act, or Obamacare, was Mr. Trump’s first major legislative move. The failure is raising questions about the administration’s ability to push forward his pro-growth agenda, which includes tax reform and a boost in infrastructure spending, analysts said. The GOP bill was pulled on Friday when it was clear the GOP didn’t have enough votes to pass it. “The problem for markets is two-fold, with the inability to pass the health care reforms meaning any tax cuts will be diminished, while markets are now left wondering whether the … [Read more...] about Wall Street hits six-week low on doubts over Trump’s agenda
Stocks 52 week low
NEW YORK Shares of Apple (AAPL) hit their lowest level in more than a year on Monday, continuing a decline hastened by the company's last quarterly earnings report. Apple stock touched as low as $419 Monday - its weakest point since January 2012 - before closing down 2.4 percent at $420.05. Time to invest in Apple? Court chops Samsung's $1B award to Apple Apple shareholder drops lawsuit on preferred stock The Cupertino, Calif., company's Jan. 23 report signaled that its fast growth phase, rare for a company of its size, may be coming to an end. Apple's stock price peaked in September at $705.07 on the day the iPhone 5 was released. With Monday's close, the stock has dropped 40 percent from the record high. … [Read more...] about Apple stock falls to latest 52-week low
Gardening might be the last thing on your mind this February, but I would still entertain the idea of adding Scotts Miracle-Gro (NYSE: SMG) to your portfolio. The home lawn-care specialist has been growing like a weed for much of the past several years. But the announcement of fiscal first-quarter 2018 results at the end of January sent shares tumbling, after a warning that growth will slow in the year ahead. That one little admission sent the stock from levels near the 52-week high to within shouting distance of the 52-week low -- in a matter of two days. It's easy to understand Wall Street's knee-jerk reaction. Scotts Miracle-Gro stock was relatively expensive, but that was justified by awesome growth. No awesome growth, no justification, and, well, look out below. While there may be some disappointment in the short term, the long-term growth potential of Scotts Miracle-Gro hasn't changed. That's why it's my top stock to buy in February. Image source: Getty Images. Slowing … [Read more...] about Here’s My Top Stock to Buy in February
On the list of the greatest investors of all time, Berkshire Hathaway CEO Warren Buffett is right at the top. Buffett's focus on buying and investing in companies with durable competitive advantages, and paying reasonable prices, has turned Berkshire into the mammoth company it is today.Many people claim to follow Buffett's approach, but there's only one Warren Buffett. Still, if you're looking to invest in stocks that are up Buffett's alley, three of our Foolish investors have some ideas. Here's why Buffett fans should consider Amazon.com (NASDAQ: AMZN), The Kraft Heinz Company (NASDAQ: KHC), and Phillips 66 (NYSE: PSX).Image source: Amazon.An investment in everything, everywhereRich Duprey (Amazon.com): There was a time when Warren Buffett wouldn't have invested in a tech stock, because, as he said, he didn't understand them. But that was a long time ago, and today he owns several. Indeed, Apple is now his single biggest holding -- which is why Amazon.com would make an excellent … [Read more...] about 3 Stocks for Warren Buffett Fans
The average price-to-earnings ratio of the S&P 500 right now is about 26 -- well above its historical average of 15.7. However, not all stocks look expensive.For example, there are some bargains to be had in the financial sector. Goldman Sachs (NYSE: GS), which recently reported disappointing trading revenue, looks very attractive from a long-term perspective. The investment bank trades for less than 13 times 2017 earnings, and has lots of potential to grow in the coming years.Real estate is another area that looks great from a long-term perspective. The sector has been beaten down lately thanks to expectations of rising interest rates. As the economy continues to strengthen, rate hikes are seen as more likely, and this is a negative catalyst for real estate investment trusts (REITs).One that I have my eye on right now is leading healthcare REIT Welltower (NYSE: HCN). Healthcare real estate is a recession-resistant property type, and Welltower's portfolio of … [Read more...] about Ask a Fool: Are there any cheap stocks left?
What happened 2017 was a year investors in Cameco Corp. (NYSE: CCJ) would want to forget, but they shouldn't, really. While shares of the uranium miner slumped 11.8% on the back of a challenging year, something happened during the tail end of 2017 that helped the stock gain some ground and could further help it sustain momentum. So what Low uranium prices and a lost contract proved to be Cameco's biggest challenges in 2017. Even as Cameco's losses widened, the ghosts of the Fukushima Daiichi nuclear disaster of 2011 that stalled the nuclear energy market came back to haunt the company when Tokyo Electric Power Company abruptly terminated a uranium supply contract with Cameco that was to run through 2028. Not surprisingly, Cameco shares trended lower for the better part of 2017 as investors, who had patiently waited for a turnaround in the uranium market, started losing what little hopes they had. Their fears were confirmed in October when Cameco reported a huge loss for its … [Read more...] about Should You Be Worried About Cameco Corp Stock’s 11.8% Drop in 2017?
SCANA stock surged in early morning trading on news that the South Carolina-based power company would be sold to Dominion Energy. Stock prices surged to a price of $46.80 after news of the sale broke Wednesday morning, up from a close of $38.87 on Tuesday – a rally of $1.2 billion for the embattled Cayce company. SCANA’s value had collapsed from a high of $73.81 this year after it was announced the troubled V.C. Summer nuclear plant the company was building with stat-owned utility Santee Cooper in Fairfield County would not be completed. Some $9 billion had been invested in the plant over a 10-year construction process. Tuesday’s close was not far off SCANA’s 52-week low of $37.10, a loss of some $5 billion in value. Stock for Virginia-based Dominion was down slightly in early trading, to $76.05 from $80.28. The average SCE&G customer, still paying $27 a month toward the project’s financing costs, will get a roughly $1,000 cash payout within 90 days of … [Read more...] about SCANA stock surges on news of SC energy sale
Insys Therapeutics (NASDAQ: INSY) was one of the worst marijuana stocks to own in portfolios in 2016 and 2017, but its shares have become a whole lot more interesting over the past couple weeks. After shares hit 52-week lows in November, they've come to life recently because of optimism surrounding the company's emerging medical marijuana research program. Will medical marijuana help Insys Therapeutics turn itself around? What's gone wrong Rapidly growing demand for Insys Therapeutics' fentanyl opioid spray, Subsys, led to a quadrupling in its shares between early 2014 and mid-2015. However, allegations of improper off-label marketing and kickbacks have since crushed the share price. IMAGE SOURCE: GETTY IMAGES. Subsys is approved for breakthrough cancer pain, but investigations that came to light in 2015 suggest most of Subsys prescriptions were for its use in other pain indications. Michael Babich, Insys Therapeutics' CEO at the time, resigned shortly thereafter, and … [Read more...] about Why This Tiny Marijuana Stock Just Doubled
If Bitcoin's too crazy a ride for you, here are 18 stocks that analysts say could enjoy their own personal bull runs in 2018.The "18 stocks for '18" list includes oil and natural gas drillers and drug makers. It also spotlights an internet travel company and high-tech firms that make the digital computing world go.This lineup of potential stars (shown below) is based on a simple methodology: They're the companies in the Standard & Poor's 500 with the biggest potential to rise when you compare their closing share price on Dec. 15 to the higher projected price targets of Wall Street analysts, using data from S&P Global Market Intelligence. Aside from strong-performing tech names, many of these stocks are considered good deals or "value plays," because their prices were beaten down in 2017 despite a nearly 20% gain for the broader market.Energy companies, which fell more than 3% in 2017 and were among the worst stock market … [Read more...] about 18 stocks that could rise 25% in 2018
If Bitcoin's too crazy a ride for you, here are 18 stocks that analysts say could enjoy their own personal bull runs in 2018.The "18 stocks for '18" list includes oil and natural gas drillers and drug makers. It also spotlights an internet travel company and high-tech firms that make the digital computing world go.This lineup of potential stars (shown below) is based on a simple methodology: They're the companies in the Standard & Poor's 500 with the biggest potential to rise when you compare their closing share price on Dec. 15 to the higher projected price targets of Wall Street analysts, using data from S&P Global Market Intelligence. Aside from strong-performing tech names, many of these stocks are considered good deals or "value plays," because their prices were beaten down in 2017 despite a nearly 20% gain for the broader market.Energy companies, which fell more than 3% in 2017 and were among the worst stock market … [Read more...] about 18 stocks that could rise 25% in ’18